Phoenix Holdings Ltd. Erytech Pharma S.A. Transaction History

Phoenix Holdings Ltd.

  • $6.66 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020
SELL
$5.7 - $8.08 $187,820 - $266,244
-32,951 Closed
0 $0
Q2 2020

Aug 10, 2020
SELL
$5.0 - $10.97 $185,245 - $406,427
-37,049 Reduced 52.93%
32,951 $267,000
Q3 2019

Nov 18, 2019
BUY
$4.23 - $7.0 $296,100 - $490,000
70,000 New
70,000 $282,000

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email